Clincosm LogoSign in Get a demo

Non-Hodgkin's Lymphoma

Showing 101 - 125 of 310
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Hodgkin's Lymphoma Trial in United States (DCDS0780A, Rituximab, Obinutuzumab)

Completed
  • Non-Hodgkin's Lymphoma
  • Duarte, California
  • +6 more
Aug 27, 2019

Non-Hodgkin's Lymphoma Trial in Worldwide (Chemotherapy (Induction Period), Rituximab)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Tirana, Albania
  • +179 more
Jul 16, 2019

Leukemia, Myelodysplastic Syndrome, Non-Hodgkin's Lymphoma Trial in New York (Cyclophosphamide)

Terminated
Has Results
  • Leukemia
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 22, 2019

Non-Hodgkin's Lymphoma Trial in Beijing (Chiauranib)

Terminated
  • Non-Hodgkin's Lymphoma
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Jul 22, 2019

FLT PET: A Pilot Study in Lymphoma Patients

Completed
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma
  • FDG PET
  • FLT PET
  • Toronto, Ontario, Canada
    The Hospital for Sick Children
Jul 22, 2019

Non-Hodgkin's Lymphoma Trial in Worldwide (temsirolimus)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Miami, Florida
  • +30 more
May 17, 2019

Follicular Lymphoma, B-cell Lymphoma, Non-Hodgkin's Lymphoma Trial in United States (Ibrutinib, rituximab)

Completed
Has Results
  • Follicular Lymphoma
  • +2 more
  • Burbank, California
  • +11 more
Mar 26, 2019

Non-Hodgkin's Lymphoma, Hodgkins Disease Trial in United States (Fludarabine, Busulfan, Anti-Thymocyte Globulin)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Hodgkins Disease
  • Chicago, Illinois
  • +5 more
Mar 4, 2019

Non-Hodgkin's Lymphoma Trial in Grand Island, Omaha (Lenalidomide, ofatumumab)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Grand Island, Nebraska
  • +1 more
Feb 20, 2019

Non-Hodgkin's Lymphoma Trial in Omaha (Dasatinib, Dasatinib Maximum Tolerated Dose)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Omaha, Nebraska
    University of Nebraska Medical Center - Internal Medicine Sectio
Jan 30, 2019

Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Multiple Myeloma Trial in Boston (drug, radiation, biological)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • +4 more
  • Boston, Massachusetts
  • +2 more
Dec 29, 2018

Non-Hodgkin's Lymphoma Trial in Seoul (Busulfan, Melphalan, Etoposide)

Completed
  • Non-Hodgkin's Lymphoma
  • Seoul, Korea, Republic of
    Soonchunhyang University Hospital
Jan 2, 2019

Solid Tumors, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in United States (PLX51107)

Terminated
  • Solid Tumors
  • +3 more
  • New York, New York
  • +4 more
Dec 20, 2018

Non-Hodgkin's Lymphoma Trial in Worldwide (Rituximab SC, Rituximab IV, Cyclophosphamide)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Rituximab SC
  • +5 more
  • Gosford, New South Wales, Australia
  • +151 more
Oct 29, 2018

Non-Hodgkin's Lymphoma, Leukemia, Multiple Myeloma Trial in Richmond (biological, radiation, procedure, drug)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • +7 more
  • Thymoglobulin
  • +4 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Nov 7, 2018

Non-Hodgkin's Lymphoma Trial in Spain (Rituximab, Bendamustine, Mitoxantrone, Dexamethasone)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Rituximab, Bendamustine, Mitoxantrone, Dexamethasone
  • Santiago, A Coruña, Spain
  • +40 more
Feb 21, 2018

Non-Hodgkin's Lymphoma Trial in Houston (Filgrastim SD/01, Paclitaxel, Topotecan)

Completed
  • Non-Hodgkin's Lymphoma
  • Filgrastim SD/01
  • +2 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Oct 29, 2018

Breast Cancer, Hypercalcemia of Malignancy, Colon Cancer Trial in Worldwide (denosumab)

Completed
Has Results
  • Breast Cancer
  • +15 more
  • Encinitas, California
  • +23 more
Sep 20, 2018

Non-Hodgkin's Lymphoma Trial in Baltimore (biological, drug, procedure)

Terminated
Has Results
  • Non-Hodgkin's Lymphoma
  • Rituximab
  • +9 more
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sep 24, 2018

Non-Hodgkin's Lymphoma Trial in Taiwan (ADI-PEG 20)

Completed
  • Non-Hodgkin's Lymphoma
  • ADI-PEG 20
  • Kaohsiung City, Taiwan
  • +4 more
Sep 13, 2018

Non-Hodgkin's Lymphoma Trial in Indianapolis (Ofatumumab combined with SB-485232)

Completed
  • Non-Hodgkin's Lymphoma
  • Ofatumumab combined with SB-485232
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Cancer Center
Aug 14, 2018

Non-Hodgkin's Lymphoma Trial in Ann Arbor, New York (bortezomib, tositumomab)

Completed
  • Non-Hodgkin's Lymphoma
  • bortezomib, tositumomab
  • Ann Arbor, Michigan
  • +1 more
Aug 9, 2018

Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in New York (device, drug, procedure)

Terminated
Has Results
  • Acute Myelogenous Leukemia
  • +4 more
  • CliniMACS® CD34 Reagent System
  • +5 more
  • New York, New York
    Weill Cornell Medical College
Jun 12, 2018

IMPACT Non Hodgkins Lymphoma (NHL) Study

Completed
  • Non-Hodgkin's Lymphoma
  • No intervention
  • (no location specified)
Jul 4, 2018

Non-Hodgkin's Lymphoma Trial in New York (PEPC, Thalidomide, Rituximab)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • New York, New York
    Weill Medical College of Cornell University
Jun 26, 2018